References and Recommended Reading
Abrams P, Kaplan S, De Koning Gans HJ, Millard R: Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. JUrol 2006, 175:999–1004.
Macdiarmid S, Chen A, Tu N, Aquilina J, Peters K: Effects of tamsulosin and extended-release oxybutynin on lower urinary tract symptoms in men [abstract 1639]. J Urol 2006, 175(Suppl 4):1–554.
Jacobsen SJ, Jacobson DJ, Girman CJ, et al.: Treatment for benign prostatic hyperplasia among community dwelling Men: the Olmsted County study of urinary symptoms and health status. J Urol 1999, 162:1301–1306.
Roehrborn CG, McConnell JD, Saltzman B, et al.: Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 2002, 42:1–6.
Rights and permissions
About this article
Cite this article
Staskin, D.R., Kaplan, S.A. & Wein, A.J. Antimuscarinic therapy in men with bladder outlet obstruction. Curr Urol Rep 7, 437–439 (2006). https://doi.org/10.1007/s11934-006-0050-9
Issue Date:
DOI: https://doi.org/10.1007/s11934-006-0050-9